• Mouse Models, Wayward Trials, and New Guidelines

    Bio-IT World Roundup | A March 26 Nature comment is getting press today. Steve Perrin, chief scientific officer at the ALS Therapy Development Institute in Cambridge, Mass., is frustrated with the mouse models driving ALS research.

    Apr 8, 2014

  • New Life for Cancer Immunotherapy

    Technology Review | Data presented at the American Association of Cancer Researchers (AACR) event over the weekend heralded the revival of cancer immunotherapy.

    Apr 7, 2014

  • Annual IT Worker Salary Survey Released

    Computerworld | Computerworld released its 2014 Salary Survey for tech workers today. Compared with last year, salaries inched up slowly, but with more employees seeing increases.

    Apr 7, 2014

  • 'Where Do I Get More Data?'

    Huffington Post | A practicing bioinformatician makes the case for genomic research organizations to make their data public.

    Apr 4, 2014

  • Schrödinger's New Platform for Real-Time Collaboration on Drug Design

    Bio-IT World | The new LiveDesign platform, released this week, allows computational and medicinal chemists to cooperate in the cloud, drawing new compounds and running predictive models on them during live sessions.

    Apr 4, 2014

  • Appistry Announces Commercial Version of GATK 3.0

    Bio-IT World News Brief | Appistry, which has managed the commercial releases of the Broad Institute's Genome Analysis Toolkit (GATK) since 2012, has released the GATK 3 for commercial use.

    Apr 3, 2014

  • Cornell Opens Center for Reproductive Genomics

    Cornell Chronicle | Cornell University has established a new Center for Reproductive Genomics (CRG) with the help of a five-year, $10 million grant from NIH.

    Apr 2, 2014

  • 23andMe Brings in New Regulatory Counsel

    Bio-IT World News Brief | This morning, 23andMe announced the appointment of industry veteran Kathy Hibbs as chief legal and regulatory officer, filling a role that has been vacant for nearly a year.

    Apr 2, 2014

  • Stem Cell Author Found Guilty of Scientific Misconduct

    Bio-IT World Roundup | A Japanese scientific committee yesterday found that the lead author of the acid-induced stem cell paper published in Nature is guilty of scientific misconduct.

    Apr 2, 2014

  • ACMG Changes Recommendations on Incidental Findings and Opting Out

    Bio-IT World | ACMG changes their recommendations on incidental findings in genomic testing, recommending that patients be given the option to opt out before testing occurs.

    Apr 1, 2014

  • Cloudera raises $900M, Intel Partnership

    ReadWrite | Cloudera just raised $900 million in its IPO, and is partnering with Intel. Intel dumped its own home-grown Hadoop distribution for Cloudera's version.

    Mar 31, 2014

  • Google Flu Trends Suffers from Inflammatory Response

    New York Times Blog | In the wake of a Science article criticizing the track record of Google Flu Trends, Steve Lohr speaks to both the article's authors and Google's engineers to understand what went wrong.

    Mar 28, 2014

  • March News and Product Briefs

    Bio-IT World | News and product releases from around the industry, including developments in gene therapy, mobile chemical modeling, and more.

    Mar 27, 2014

  • Toby Bloom on the New York Genome Center’s Crystallizing Clinical Vision

    Bio-IT World | With almost a year behind her, Toby Bloom, the New York Genome Center’s Deputy Science Director, Informatics, talks about the Center’s new projects, its clinical vision, and her dreams of a “be-all, end-all” multimodal database for genomic and clinical data.

    Mar 26, 2014

  • Bina Rebrands Offerings, Adds Bina Desktop to Lineup

    Bio-IT World | Bina Technologies announced the details of their new desktop offering, Bina Desktop, this morning, along with a rebranding of their products.

    Mar 25, 2014

  • DNA Mugshots

    Nature News | In a paper in PLOS Genetics, researchers showed how 24 gene variants could construct crude 3-D models of a face.

    Mar 24, 2014

  • 23andMe Pursues Health Research in the Shadow of the FDA

    Bio-IT World | Four months after the FDA barred 23andMe from reporting genetic disease risks to customers, the in-house research team insists that "the mission of the company remains on health."

    Mar 24, 2014

  • Remembering Pat McGovern

    Bio-IT World | Patrick McGovern died on March 19, at Stanford Hospital, in Palo Alto, California. Among his many important achievements Pat McGovern was the Godfather of Bio-IT World.

    Mar 21, 2014

  • 2014 Bio-IT World Expo Preview

    Bio-IT World | This year’s Bio-IT World Conference & Expo in Boston (April 29-May 1, 2014) will once again play host to thousands of industry and academic colleagues discussing big data, security, cloud computing, trends in IT infrastructure, omics technologies, high-performance computing, data analytics and precision medicine, over three days, across 13 tracks.

    Mar 20, 2014

  • Broad, Intel Announce Speed Improvements to GATK Powered by Intel Optimizations

    Bio-IT World | The Broad Institute has announced that a new version of the Genome Analysis Toolkit (GATK), version 3.1, has been released and has been optimized for Intel Advanced Vector Extensions (Intel AVX). The improvements account for faster variant calling, achieving three to five times overall improvement in variant discovery.

    Mar 20, 2014